Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CleanSpace HoldingsASX:CSX +9.72%21 Cash-to-Debt is 6.25 as of Dec. 2025, which is 25% above its 10-year median of 4.99. GuruFocus rates ASX:CSX with a GF Score™ of 21/100 and a GF Value™ of A$0.56 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 847 Medical Devices & Instruments companies, CleanSpace Holdings ranks better than 69.54% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. CleanSpace Holdings's cash to debt ratio for the quarter that ended in Dec. 2025 was 6.25.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, CleanSpace Holdingscould pay off its debt using the cash in hand for the quarter that ended in Dec. 2025.
The historical rank and industry rank for CleanSpace Holdings's Cash-to-Debt or its related term are showing as below:
ASX:CSX'
s Cash-to-Debt Range Over the Past 10 Years
Min: 2.31 Med: 4.99 Max: 12.92
Current: 6.25
During the past 6 years, CleanSpace Holdings's highest Cash to Debt Ratio was 12.92. The lowest was 2.31. And the median was 4.99.
ASX:CSX's Cash-to-Debt is ranked better than 69.54% of 847
companies
in the Medical Devices & Instruments industry
Industry Median: 1.68
vs ASX:CSX: 6.25
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
CleanSpace Holdings Cash-to-Debt Related Terms
CleanSpace Holdings Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for CleanSpace Holdings's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Medical Devices subindustry, CleanSpace Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CleanSpace Holdings Cash-to-Debt vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CleanSpace Holdings's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where CleanSpace Holdings's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CleanSpace Holdings (ASX:CSX) has a Cash-to-Debt of 6.25 as of Dec. 2025. This is 25% above median its historical median of 4.99. Over the past decade, CleanSpace Holdings' Cash-to-Debt has ranged from 2.31 to 12.92. According to the industry distribution chart, CleanSpace Holdings ranks #258 out of 847 companies in the Medical Devices & Instruments industry, placing it in the top 30.5%.
Is CleanSpace Holdings' Cash-to-Debt too high?
CleanSpace Holdings' current Cash-to-Debt of 6.25 is 25% above median its 10-year median of 4.99. Over the past 10 years, this metric has ranged from a low of 2.31 to a high of 12.92. The Medical Devices & Instruments industry median Cash-to-Debt is 1.68. CleanSpace Holdings' value of 6.25 is 272% above this industry median. Based on the distribution chart, CleanSpace Holdings ranks #258 out of 847 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, CleanSpace Holdings has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CleanSpace Holdings' Cash-to-Debt compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CleanSpace Holdings ranks #258 out of 847 companies for Cash-to-Debt. This puts CleanSpace Holdings in the upper half of its industry. The industry median Cash-to-Debt is 1.68. CleanSpace Holdings' value of 6.25 is 272% above this benchmark. Historically, CleanSpace Holdings' own Cash-to-Debt has ranged from 2.31 to 12.92 over the past decade. While the company's 10-year median is 4.99 vs. the industry median of 1.68, CleanSpace Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Devices & Instruments company?
The median Cash-to-Debt among Medical Devices & Instruments companies is 1.68, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CleanSpace Holdings's current Cash-to-Debt of 6.25 is 272% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Cash-to-Debt is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CleanSpace Holdings's current Cash-to-Debt is 6.25, which is 25% above median its own 10-year median of 4.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CleanSpace Holdings stock overvalued right now?
Based on GuruFocus' analysis, CleanSpace Holdings (ASX:CSX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.56, compared to a current price of A$0.40 — trading 29.5% below its estimated fair value. The current Cash-to-Debt is 6.25, which is 25% above median its 10-year median of 4.99 and 272% above the Medical Devices & Instruments industry median of 1.68. CleanSpace Holdings' overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For CleanSpace Holdings (ASX:CSX), the current Cash-to-Debt is 6.25 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CleanSpace Holdings (ASX:CSX) Overvalued in 2026?
Based on GuruFocus' analysis, CleanSpace Holdings stock appears to be undervalued.
The current stock price of A$0.40 is trading 29.5% below its estimated GF Value™ of A$0.56.
GuruFocus considers CleanSpace Holdings to be Modestly Undervalued.
Key valuation signals for ASX:CSX:
Cash-to-Debt: 6.25 (25% above median its 10-year median of 4.99)
GF Value™: A$0.56 vs. price of A$0.40 (29.5% below fair value)
Industry Position: 272% above the Medical Devices & Instruments median (#258 of 847)
No single metric tells the full story. See the ASX:CSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CleanSpace Holdings Ltd manufactures and sells respirators and related products and services. Its products include Compare, CleanSpace HALO, CleanSpace ULTRA, Masks, Filters, and Compatible Products. The company's operating segment is based on regions that include, Europe, Asia, and North America, and the majority of its revenue is generated from Europe.
21GF Score
Get the complete analysis for ASX:CSX
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CSX has been successfully added to your 
